Explore
Trendline
IDEAYA Biosciences to Present Phase 2/3 Trial Data on Darovasertib at ASCO 2026
IDEAYA Biosciences to Present Phase 2/3 Trial Data on Darovasertib at ASCO 2026
Read More
Trendline
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Submissions
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Submissions
Read More
SB Nation
Phillies news: Zack Wheeler, Dave Dombrowski, Munetaka Murakami
Yikes
Read More
Trendline
Forlong Biotechnology to Present Clinical Data on FL115 at ASCO 2026
Forlong Biotechnology to Present Clinical Data on FL115 at ASCO 2026
Read More
Trendline
Pfizer Presents Oncology Innovations at ASCO 2026, Highlighting New Cancer Treatment Strategies
Pfizer Presents Oncology Innovations at ASCO 2026, Highlighting New Cancer Treatment Strategies
Read More
Trendline
Forlong Biotechnology to Present Clinical Data on FL115 for Advanced Solid Tumors at ASCO 2026
Forlong Biotechnology to Present Clinical Data on FL115 for Advanced Solid Tumors at ASCO 2026
Read More
Trendline
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Regulatory Submissions
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Regulatory Submissions
Read More
Trendline
Dizal to Present Key Developments in NSCLC Treatments at ASCO 2026
Dizal to Present Key Developments in NSCLC Treatments at ASCO 2026
Read More
Trendline
Missouri Tigers Basketball to Face Marquette in Neutral-Site Game in Chicago
Missouri Tigers Basketball to Face Marquette in Neutral-Site Game in Chicago
Read More
Trendline
Obsidian Therapeutics to Present Phase 2 Data on OBX-115 for Advanced Melanoma at ASCO
Obsidian Therapeutics to Present Phase 2 Data on OBX-115 for Advanced Melanoma at ASCO
Read More
SB Nation
Utah wins a coin flip: somewhere, Sam Presti utters a profanity
What a relief!
Read More
Trendline
Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence
Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence
Read More
